About
Eleos builds AI software for behavioral health, substance-use-disorder, and community-based care organizations, automating documentation, compliance, revenue-cycle, and clinical-insight workflows. Its differentiation is purpose-built voice-based natural-language understanding and workflow agents that integrate with existing EHRs, telehealth tools, and provider processes.
Market
Eleos competes in healthcare AI software for behavioral health, substance-use disorder, community-based care, and post-acute providers, spanning ambient documentation, clinical insights, compliance automation, and revenue-cycle management. It positions itself as a broader “system of action” rather than a standalone AI scribe, differentiating through purpose-built clinical AI, EHR-embedded workflows, and agents that identify and resolve problems before documentation sign-off, claims submission, or reimbursement loss.
Eleos primarily serves provider organizations in behavioral health, substance-use disorder treatment, and community-based post-acute care, including home health, palliative, and hospice providers. Its likely buyers and users are clinical, compliance/quality, and revenue-cycle leaders seeking to reduce documentation burden, improve care decisions, prevent compliance issues, and protect reimbursement.
At a Glance
Problem
Behavioral health providers must turn complex therapy, psychiatry, and substance-use sessions into detailed, clinically useful, compliant progress notes while preserving attention for the person in front of them. Manual documentation consumes substantial provider time, contributes to burnout and turnover, and creates costly compliance exposure through clawbacks, rework, audit penalties, and labor-intensive quality reviews. The central use case is helping a clinician finish an accurate, compliant note immediately after a session rather than spending additional hours reconstructing it.
Product / Service
Eleos offers an AI platform purpose-built for behavioral health, centered on Eleos Documentation, an ambient AI scribe available on desktop and mobile. It captures live session audio or accepts short provider summaries, converts them into structured note suggestions, and lets the clinician review and edit the result before finalizing it. The product supports in-person and telehealth workflows, embeds into existing EHR processes without requiring APIs or integrations, and can generate suggestions in more than 150 languages. Eleos reports that providers receive more than 80% of note content within minutes and spend 70% less time on documentation.
The platform also includes Eleos Compliance, which automatically reviews eligible progress notes across six compliance domains. This shifts quality and compliance teams from manually auditing every note to concentrating on exceptions and problem areas, with the intended benefits of faster feedback, stronger medical-necessity documentation, improved care continuity, and reduced administrative burden.
Market
Eleos competes in the behavioral-health technology market, specifically AI documentation, clinical workflow automation, and compliance software for community behavioral-health and substance-use-disorder organizations. Its stated coverage spans individual and group therapy, psychiatry, and other behavioral-health specialties. The available research does not identify a named direct competitor; Streamline Healthcare Solutions’ SmartCare EHR appears as an integration and distribution partner rather than a competitor.
The company was founded in 2020 and has evidence of commercial traction, including a 4.9-star G2 rating based on 12 reviews and selection in February 2026 as the official AI partner of the California Mental Health Services Authority. That partnership gives county behavioral-health departments across California access to Eleos documentation and compliance capabilities inside Streamline’s SmartCare platform. The available evidence does not disclose revenue, so Eleos should not be characterized as either revenue-generating or pre-revenue on this record.
Founders & Leadership
Funding History
Lool Ventures
aMoon Fund
F-Prime Capital, Eight Roads Ventures
Menlo Ventures
Greenfield Partners
Recent News
Eleos announced new AI agents spanning clinical insights, revenue cycle management, and compliance automation. The capabilities are designed to surface clinical, eligibility, coding, and compliance risks in real time across behavioral health, SUD, and care-at-home settings.
California’s Mental Health Services Authority selected Eleos as its statewide AI partner alongside Streamline Healthcare Solutions’ SmartCare EHR. The partnership will give 27 California counties access to Eleos’ AI-powered documentation and compliance capabilities within the EHR platform.
Eleos raised a $60 million Series C led by Greenfield Partners, bringing total funding to more than $120 million. The company planned to use the capital for new products, commercial expansion, and growth in underserved behavioral-health segments, particularly substance-use-disorder treatment.
Eleos announced that it earned ISO/IEC 42001:2023 certification for its artificial-intelligence management system. The certification validates its framework for responsible AI development, transparency, bias mitigation, security, and risk management.
Eleos launched Polaris AI in collaboration with Google Cloud, combining Google Cloud’s multimodal models and infrastructure with Eleos’ clinically focused data and technology. The audio-native model is intended to reduce documentation burden, strengthen compliance, and interpret nuanced clinical conversations.
Eleos completed Drummond’s pDSI Risk Certification program for predictive decision-support interventions. The review confirmed safeguards for intervention-risk management, source attribution, explainability, governance, and disclosure of intended uses and risks.
Eleos launched Groups, an AI capability that produces individual speaker summaries for group-therapy notes. The solution is designed for SUD providers and supports real-time, multi-speaker sessions across in-person and telehealth settings while preserving HIPAA-compliant handling of audio.
Eleos introduced the OBBBA AI scanner to identify conversational clues that may signal changes in Medicaid eligibility during client sessions. The tool helps providers act before coverage lapses, reducing care disruption, denials, and reimbursement risk amid new Medicaid rules.
Active Roles
15Business Model
Eleos sells a B2B AI software platform to behavioral-health and other care organizations through a demo-led enterprise sales process. Clients typically engage through annual or multi-year contracts, while the company does not publish standard per-seat pricing.
Products
Customers
Tech Stack
Similar Companies
Competitors
Key Investors
Greenfield Partners, F-Prime Capital, Eight Roads, Menlo Ventures, ION, Michael & Susan Dell Foundation, Union Tech Ventures, Centerstone